Ledger.Open graph →
SEC Form D · Amendment · filed July 2, 2024

General Oncology, Inc

Offering
$11.3M
Sold
$7.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BROOKLINE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Arnold A. Glazier · Brookline, MAExec · DirectorMichael D. Sigman · Brookline, MADirectorJeffrey A. Glazier · Brookline, MAExecGregg Goldstein · Brookline, MAExec · DirectorMichael J. Petit · Brookline, MADirectorJeffrey A. Glazier · Brookline, MAExecGregg Goldstein · Brookline, MAExec · DirectorMichael D. Sigman · Brookline, MADirectorArnold A. Glazier · Brookline, MAExec · DirectorMichael J. Petit · Brookline, MADirectorMark Jackson · Birmingham, ALExec · DirectorSteve Dauphin · Birmingham, ALExec · DirectorDavid Masom · Birmingham, ALDirectorCaroline Crumley · Birmingham, ALDirectorBlake R. Apel · DALLAS, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗